Provisional decision on remedies
here.
See also Appendices 4.1 (Single-homing and the threat of delisting), 4.2 (Extending the remedy to narrow MFNs), and 4.3 (Effectiveness of advertising expenditure on PCWs),
here.
Remedy proposed (para 4.71):
(a) A prohibition on PCWs and PMI providers entering into or performing agreements that include an MFN relating to the sale of PMI,
except narrow MFNs, where ‘narrow MFNs’ are defined as covering the insurance provider website but excluding possible aggregator platforms.
(b) A prohibition on behaviours which have as their effect the elimination or reduction of competition between PCWs
in a similar way to the harm identified by wide MFNs (namely, restricting entry to the PCW market, reducing innovation by PCWs and increasing premiums for motor insurance to the retail customer). This measure will apply to those PCWs which generate more than 300,000 PMI sales per year
[this would mean that narrow MFNs which have the same anticompetitive effects as wide MFNs are also prohibited, SV ]
(c) PMI providers and PCWs will be required to comply with immediate effect following the making of the order.
(d) In order to monitor equivalent behaviours, those PCWs above the 300,000 PMI sales per year threshold will be required to submit compliance statements to the CMA every quarter for the first two years following the order and then once a year. These compliance statements would
need to list all delisting actions during the relevant period, setting out the
reasons for the delisting.
